Susan T. Weaver
Known title: DirectorCIK: 0001687804
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
ADUS: No new company-specific news in last 7 days. There is no recent news specific to Addus HomeCare Corporation in the provided data. The only article listed concerns a different company, Hims & Hers, and is not relevant to ADUS. Therefore, no company-specific developments can be summarized for this period.
Transaction History
| AHCO | ▲ Buy | Grant | 18,999 | $0 | 6/24/2026 | View on chart |
| ADUS | ▲ Buy | Grant | 1,449 | $0 | 6/10/2026 | View on chart |
| AHCO | ▼ Sell | Gift | 73,472 | $0 | 3/5/2026 | View on chart |
| AHCO | ▼ Sell | Gift | 73,472 | $0 | 3/5/2026 | View on chart |
| AHCO | ▲ Buy | Grant | 21,346 | $0 | 6/26/2025 | View on chart |
| ADUS | ▲ Buy | Grant | 1,172 | $0 | 6/18/2025 | View on chart |
| AHCO | ▲ Buy | Grant | 15,629 | $0 | 6/24/2024 | View on chart |
| ADUS | ▲ Buy | Grant | 1,013 | $0 | 6/12/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 15,949 | $0 | 6/22/2023 | View on chart |
| ADUS | ▲ Buy | Grant | 1,289 | $0 | 6/14/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 9,321 | $0 | 6/22/2022 | View on chart |
| ADUS | ▲ Buy | Grant | 1,406 | $0 | 6/15/2022 | View on chart |
| AHCO | ▲ Buy | Grant | 4,509 | $0 | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list
A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.